News Releases

LONDON, U.K. AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces the appointment of Stifel Nicolaus Europe Limited as

LONDON, U.K. AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has granted options (“Options”)  over 250,000

Spectral MD has achieved all the project milestones it set to be achieved by this time in 2021 and has achieved other important milestones ahead of schedule, including early receipt of increased U.S. Government grant funding of  c. US$20 million post-IPO and progress on new burn and DFU patient

LONDON, U.K AND DALLAS, TX, U.S  –  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that its interim results for the six month period ended

Funds will expand the DeepView training clinical study for burn wound Total funding commitments of c. $93m received from BARDA to date to support the development of Spectral MD’s artificial intelligence and multi-spectral imaging for wound healing assessment LONDON, U.K.

Start of multi-center clinical study to further develop its DeepView® Wound Imaging System and burn wound-healing prediction AI Algorithm LONDON, U.K AND DALLAS, TX, U.S  –  Spectral MD Holdings, Ltd. (AIM:SMD), a predictive analytics company that develops proprietary AI algorithms and optical

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS  (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)  i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached  ii : Spectral

US$1.1 million awarded to advance Spectral MD’s AI wound healing assessment technology for use in a far-forward military environment and to improve portability LONDON, U.K. AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI

LONDON, U.K. AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd., a predictive analytics group that develops proprietary AI algorithms and optical technology for faster treatment decisions in wound care, is pleased to announce the admission of its entire issued share capital, being 136,077,064 shares

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF IRELAND, THE REPUBLIC OF SOUTH AFRICA OR